MB Biotech innovations Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 9,652 |
| - |
| -1,358 |
| -1,358 |
| - |
| 78.23 |
| -14.07 |
| 642 |
| 5,141 |
| 0 |
| 5,783 |
Register and
explore Okredo data| 2024 |
|---|
| 9,652 |
| - |
| -1,358 |
| -1,358 |
| - |
| 78.23 |
| -14.07 |
| 642 |
| 5,141 |
| 0 |
| 5,783 |
Register and
explore Okredo data2024
Turnover (€)
9,652 €
- *
Sales per employee (€)
-Profit before tax (€)
-1,358 €- *
Net Profit (€)
-1,358 €- *
Profit per employee (€)
-Total profitability (%)
78.23 %- *
Net profitability (%)
-14.07 %- *
Equity (€)
642 €- *
Amounts Payable And Liabilities (€)
5,141 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
5,783 €- *